Randall J. Weisenburger
Analyst · UBS
Thank you, John. As John said, our agencies had an excellent performance in Q2, benefiting from their continuous focus on delivering new, innovative and insightful ideas and services to their clients, while relentlessly driving their own cost efficiencies. As a result, revenue came in right on track at $3.6 billion, and our EBITA margin for the quarter increased almost 20 basis points to 15.1%, bringing EBITA for the quarter up to $548 million. Operating income or EBIT for the quarter increased 3.3% to $523 million, and the resulting operating margin was 14.4%, also a year-over-year improvement of about 20 basis points. Looking at the items below operating income, net interest expense for the quarter was $40.7 million, up $5.8 million from Q2 of last year and just about flat with the first quarter. The year-over-year increase is primarily due to the interest cost on the $1.25 billion of 10-year notes we issued last year. If you remember, the first tranche of $750 million was issued early in Q2, and the second tranche of $500 million was issued mid-Q3. Together, they have a blended interest rate of about 3.4%. On the tax front, our reported rate for the quarter was 33.9%. While the rate was down slightly from last year, there were a few ups and downs in the quarter from discrete items that pushed the rate up just a bit. For the full year, we still expect our operating tax rate to be around 33.6%, which is about where we are for the first 6 months. Net income for the quarter was $289.5 million, which was a solid increase of 2.4%. And on Slide 3, we show the computation of diluted EPS. The increase in net income, combined with the year-over-year reduction in our diluted share count of 4.6%, resulted in EPS for the quarter of $1.09, which was an increase of 6.9%. On Slide 4, we take a closer look at our revenue performance. First, with regard to FX, on a year-over-year basis, the U.S. dollar strengthened against most of our major currencies, except for the euro and the Chinese yuan. The net result reduced revenue in the quarter by $18.7 million or about 0.6%. Looking ahead, if rates stay where they are currently, we expect FX to be negative by about 1% in Q3 and about 1.5% in Q4. Revenue from acquisitions net of dispositions decreased revenue by $4.3 million. And in the quarter, we completed the sale of our recruitment marketing business, so for the next few quarters, absent new acquisitions, we could have negative acquisition revenue of between 70 and 100 basis points. With regard to organic growth, we had another very solid quarter, up 2.8% or $99 million. As we've talked about before, this quarter, we were up against strong comparables, including specific Olympic-related revenue of about $50 million. A couple other areas worth mentioning this quarter. We continue to have excellent performance from our media operations, driven by both solid new business activities and new services. Our specialty pharma and health care businesses are benefiting from a combination of recent wins and increased activity from clients. And our agencies in many of the emerging markets, China, Russia, India, the U.A.E., Turkey, Colombia and Chile, to name a few, continue to have strong double-digit growth. Turning to our mix of revenue by discipline on Slide 5. Brand advertising accounted for 48% of our revenue; and marketing services, 52%. As for their respective growth rates, brand advertising's organic growth was 4.3%, driven by strong growth in our media businesses, as well as good new business performance in the second half of last year. However, this was offset to some extent by recent moves of Gillette and Chevy. And our marketing services was up 1.4% in aggregate. Within marketing services, CRM was down 0.5%, primarily driven by declines in our sports and events businesses when compared to the second quarter of last year, when they had the benefit of significant Olympics-related revenues. Our public relations businesses continue to have very good results, posting organic growth of 3.8%. And specialty communications had an outstanding quarter, up 7.8%, predominantly driven by strong results across the board from our specialty health care businesses. On Slide 6 and 7, our geographic mix of business in the quarter was split 52% domestic and 48% international. In the United States, revenue increased $44.4 million or 2.4%. Organic growth continue to be very solid, up 2.7%, and acquisitions net of dispositions was down $6.7 million or 0.3%. International revenue increased $32 million or about 1.9%. FX created a headwind, causing revenue to decline $19 million. Acquisitions net of dispositions increased revenue $2.4 million, and organic growth, which continues to be very mixed by region, increased this quarter to 2.8% or $48 million. In Europe, of the larger countries, Russia and the U.K. continue to perform very well, while Germany and France were down. In the U.K., increased spending by our consumer products and telecom clients led our traditional agencies, especially our media agencies, to a solid quarter. The Eurozone markets, in aggregate, were down 3% organically. And in Asia, we had strong performances across most of the region, with double-digit growth in China, India, Hong Kong, Singapore, Thailand, Malaysia and Indonesia. And in Latin America, we continue to have standout results in Brazil, Chile and Colombia. Slide 8 shows our mix of business by industry. As the chart shows, we had strong performances in the quarter in the travel and entertainment sector, which was primarily driven by a couple of recent new business wins, as well as the consumer products, telecom and pharma sectors, which resulted from a balance of new business wins and increased spending. Obviously, we were down in the auto sector, primarily due to the Chevy move. Turning to Slide 9. Our cash performance for the first 6 months of the year was on track and consistent with last year. We generated just over $700 million of free cash flow, excluding changes in working capital. On Slide 10, the breakdown of our primary uses of cash over the same 6 months included dividends to our common shareholders of about $107 million. The year-over-year decrease reflects the fact that we accelerated our normal January dividend payment to December of last year. Dividends paid to minority interest shareholders of $60 million and capital expenditures of $69 million. CapEx this year is down year-over-year, primarily due to a couple of sizable office moves and a long-term lease renewal that occurred last year that had significant build-outs involved. Acquisitions including earn-out payments, net of the proceeds received from the sale of investments, totaled $45 million. And share repurchases, net of the proceeds received from stock issuances under our employee share plans, totaled $492 million. All in, we overspent our free cash flow by about $71 million for the 6 months. Slide 11 shows our current capital structure. As we believe everyone's aware, we redeemed $407 million of our convertible notes during the second quarter for a combination of cash and stock. That reduced the amount of convertible notes outstanding down to $253 million. And that, coupled with the second tranche of senior notes issued in Q3 of 2012, brings our total debt balance up to just over $4 billion. Also, year-over-year, our net debt position increased by $377 million to $2.63 billion, primarily as a result of share buybacks over the past 12 months. As a result of the increased debt, our total debt-to-EBITDA ratio stands at 1.9x, and our net debt-to-EBITDA ratio is only 1.2x. Our interest coverage ratio, at 10.8x, remains very strong. On Slide 12, we show our ROIC and our ROE metrics, both of which continue to be very strong. Our return on invested capital for the trailing 12-month period increased to 17.5%, and our return on equity for the same period increased to almost 32%. And finally on Slide 13, which tracks the total cash payout to shareholders, shows that since 2002, we've returned just over 100% of our net income to shareholders through the combination of dividends and share repurchases. And that concludes our prepared remarks. There are several other supplemental slides included in the presentation materials for your review. But at this point, I'm going to ask the operator to open the call for questions.